References
1. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464.
2. Head K, Chong LY, Hopkins C, Philpott C, Schilder AG, Burton MJ. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:CD011992.
3. Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AG. Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:CD011991.
4. Price D, Castro M, Bourdin A, Fucile S, Altman P. Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety. European respiratory review : an official journal of the European Respiratory Society. 2020;29(155).
5. Hopkins C, Slack R, Lund V, Brown P, Copley L, Browne J. Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Laryngoscope. 2009;119(12):2459-65.
6. Hopkins C, Browne JP, Slack R, Lund VJ, Topham J, Reeves BC, et al. Complications of surgery for nasal polyposis and chronic rhinosinusitis: the results of a national audit in England and Wales. Laryngoscope. 2006;116(8):1494-9.
7. Kim C, Han J, Wu T, Bachert C, Fokkens W, Hellings P, et al. Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review. Otolaryngol Head Neck Surg. 2021;164(1):57-66.
8. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020;58(2):82-111.
9. Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74(12):2312-9.
10. Fitch K BS, Aguilar MD, Burnand B, LaCalle JR. The RAND/UCLA appropriateness method user’s manual. RAND CORP SANTA MONICA CA;2001.
11. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR. The RAND/UCLA appropriateness method user’s manual. RAND CORP SANTA MONICA CA; 2001.
12. Rudmik L, Beswick DM, Alt JA, Bhattacharyya N, Chester AC, Gray ST, et al. Appropriateness Criteria for Surgery in the Management of Adult Recurrent Acute Rhinosinusitis. The Laryngoscope. 2019;129(1):37-44.
13. Amin N, Walker A, Alobid I, Anari S, Bast F, Bhalla RK, et al. Defining appropriateness criteria for endoscopic sinus surgery in the management of adult dental implant patients with incidental maxillary sinus findings on conebeam computed tomography. Clin Otolaryngol. 2020.
14. Hopkins C, Alanin M, Philpott C, Harries P, Whitcroft K, Qureishi A, et al. Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines. Clin Otolaryngol. 2021;46(1):16-22.
15. Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638-50.
16. Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146(3):595-605.
17. Bachert C, Sousa AR, Lund VJ, Scadding GK, Gevaert P, Nasser S, et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial. J Allergy Clin Immunol. 2017;140(4):1024-31 e14.
18. Scangas GA, Wu AW, Ting JY, Metson R, Walgama E, Shrime MG, et al. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps. Laryngoscope. 2021;131(1):E26-E33.
19. Tice JA WJ, Synnott P, Kumar V, Adair E, Rind D, et al. Biologic Therapies for Treatment of Asthma Associated with Type 2 Inflammation. Inst Clin Econ Rev. 2018;1–132.
20. Hopkins C, Lund V. Does time from previous surgery predict subsequent treatment failure in Chronic Rhinosinusitis with Nasal Polyps? Rhinology. 2021(In press).
21. van der Veen J, Seys SF, Timmermans M, Levie P, Jorissen M, Fokkens WJ, et al. Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre. Allergy. 2017;72(2):282-90.
Legends
Figure 1a Agreed criteria where it was considered appropriate to consider treatment with a biologic
Figure 1b Agreed criteria where it was considered not to be appropriate to consider treatment with a biologic